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Abstract  14 
Purpose: Capture change in family members' experiences as they look after patients during 15 
chemotherapy, and understand variability in their needs for support.   16 
Method: Longitudinal digitally-recorded qualitative semi-structured interviews with family carers at 17 
the beginning, mid-point, and end of treatment. Twenty-five family members (17 women, 8 men), 18 
mean age 52, were interviewed. Fifteen participants were supporting a relative having 19 
chemotherapy with curative intent, and 10 a patient receiving palliative chemotherapy. They were 20 
recruited from two UK locations: a regional cancer centre in Southampton and a comprehensive 21 
cancer centre in London. Sixty-three interviews were conducted in total, and the data were analysed 22 
using Framework Analysis. 23 
Results: Three themes were generated from the data: Changing lives, Changing roles; Confidence in 24 
caring, and Managing uncertainty.  These captured family carers' evolving needs and sense of 25 
confidence in caregiving during chemotherapy. Carers reported considerable anxiety at the outset of 26 
treatment which persisted throughout.  Anxiety was underpinned by fears of disease recurrence or 27 
progression and concerns about treatment outcomes.   28 
Conclusions: This study presents original fine-grained work that captures the changes over time in 29 
family carers' experiences of chemotherapy and their adaptation to caregiving. It provides 30 
fundamental evidence of the challenges that cancer carers face during patients' treatment; evidence 31 
that can be used as a basis for carer assessment and to build much-needed carer interventions. 32 
Oncology nurses should assess carers': ability to care; needs for information and support to prepare 33 
them for this; wellbeing over time; and, any support they may require to prevent them from 34 
becoming overburdened. 35 
Keywords   cancer; chemotherapy; family carers; longitudinal; qualitative; support needs 36 
 37 
Highlights 38 




Family members’ confidence in caregiving can grow as treatment progresses as long as they can 40 
access appropriate help when needed. 41 
For carers of people having curative chemotherapy, anxiety and stress appear to accumulate over 42 
the treatment journey. 43 
Carers’ experiences and needs should be assessed at multiple time points to enable healthcare 44 
professionals to respond effectively to their support needs.  45 
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1. Introduction  46 
A cancer diagnosis profoundly affects both patients and their family and friends.   In the 47 
United Kingdom, over 360,000 people are diagnosed with cancer annually (Cancer Research UK, 48 
2018), and about 1.5 million people provide informal care for them (Macmillan Cancer Support, 49 
2016). Informal carers - people including family and friends who give unpaid support to people with 50 
cancer - adopt a number of roles.   During chemotherapy, these roles include being an advocate, 51 
companion, protector and practical caregiver (McIlfatrick et al., 2006; Ream et al., 2013).  Further, 52 
carers provide patients with significant emotional and physical support, assist with symptom 53 
management, help administer medicines and coordinate care (Ullgren et al., 2018).  54 
Supporting someone through cancer comes at a cost.  Carers can experience extreme strain, 55 
anxiety and distress (Grimm et al., 2000; Aranda & Hayman-White, 2001; Matthews, et al., 2003; 56 
Deshields et al., 2012; Lambert et al., 2016).  This is particularly pronounced during chemotherapy 57 
(Renovanz et al., 2018), a treatment associated with toxicities that can prove life-threatening at 58 
worst (NCEPOD, 2008) and impact quality of life at best. It evokes considerable fear (Bell, 2009; 59 
Hofman et al., 2004) in patients and carers and their anxiety is compounded by chemotherapy 60 
typically being provided in outpatient settings.  This requires them to monitor and manage side-61 
effects at home (McIlfatrick et al., 2006; McKenzie et al., 2017; Ullgren et al., 2018).  62 
Carers report that their needs for information and support are often overlooked by 63 
healthcare professionals (Ussher et al., 2009) and consequently go unmet (Sklenarova et al., 2015).  64 
They report low self-efficacy in providing care , insecurity around both managing chemotherapy 65 
side-effects and recognising changes in patients’ health (Williams et al., 2013) and concerns over 66 
ensuring patients’ safety during chemotherapy (Applebaum and Breitbart, 2013).  67 
Through developing a fine-grained understanding of carers’ needs for support during cancer 68 
treatment, healthcare professionals can develop, evaluate and implement pertinent interventions to 69 
alleviate carer distress and enhance their caregiving capacity. While a number of studies have 70 
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reported on carers’ support needs during chemotherapy (McIlfatrick et al., 2006; Ream et al., 2013; 71 
Norton et al., 2019), few have examined these over time; a perspective that would give insight into 72 
how carers’ support needs and confidence in caregiving change as treatment unfolds. Some studies 73 
have used a longitudinal approach when exploring  cancer carers’ experience more generally 74 
(Murray et al., 2010; Girgis et al., 2013; Walshe et al., 2017; Roberts et al., 2018) but the challenges 75 
faced by carers during chemotherapy have not featured. Few interventions have been developed to 76 
address carer needs during chemotherapy (Tsianakas et al., 2015).  77 
We sought to address the evidence gap by undertaking a longitudinal qualitative study to 78 
describe carers’ experiences whilst supporting relatives through chemotherapy and to explore how 79 
their support needs and caregiving confidence evolved during of treatment. We focused on the 80 
needs of family members as they predominantly – over friends – provide this support.  We 81 
purposively sampled family members of people having either curative or palliative treatments in 82 
order to gain understanding of how this context may impact experience.  Such inquiry has not been 83 
undertaken to date.   84 
 85 
2. Methods  86 
2.1. Design 87 
A longitudinal qualitative design was adopted, entailing digitally-recorded semi-structured 88 
interviews conducted with family carers at three points during patients’ treatment with intravenous 89 
chemotherapy: start of treatment (T1), mid-point (T2) i.e. point where half of the planned cycles of 90 
chemotherapy had been administered, and completion of chemotherapy (T3). Interviews focused on 91 
carers’ need for information and support from healthcare professionals and factors that affect their 92 
confidence and competence in caring for someone over the course of chemotherapy.  Analysis of 93 
longitudinal data can provide rich understandings of changes and/or stability over time, factors that 94 
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may account for these, and both how and why experiences may vary between individuals (Saldaña, 95 
2003; Calman et al., 2013). 96 
 97 
2.2. Participants 98 
We specifically sought carers of people having combination chemotherapy treatments 99 
incorporating cisplatin; these treatments produce significant toxicity and, it was envisaged, would 100 
give insight into how carers would manage difficult side-effects. Carers were identified by 101 
patients and recruited from a comprehensive cancer centre in London and a regional cancer centre 102 
in Southampton, in the south of England, between April 2011 and May 2012. Patients new to 103 
chemotherapy were screened for eligibility by the clinical team and approached for consent to 104 
recruit the family member they considered their principal provider of care. Patients were usually 105 
approached when they attended a pre-treatment consultation. Eligible patients were: receiving 106 
cisplatin-based chemotherapy for gynaecological, lung, testicular or colorectal cancer; over 18 years; 107 
willing for their family member to be approached; able to communicate in English; having first ever 108 
course of chemotherapy; and without any cognitive impediment. Eligible carers were: family 109 
members nominated by patients as providing most support; over 18 years; able to communicate in 110 
English; and able to comply with the research protocol. 111 
Twenty-five participants were sought. This sample size reflects recommendations that 112 
qualitative researchers interview fewer than 50 interviewees (Ritchie and Lewis, 2003) in order to 113 
maintain quality of data collection and allow in-depth analysis. Further, it is suggested that limited 114 
new information is revealed when more than 25-30 participants are interviewed (Hennink et al., 115 
2017). In this study, the research teams in Southampton and London reviewed collectively the data 116 
every two weeks to establish the point at which no new information was being generated - 117 
information that would either enhance or alter the study findings – indicating that data saturation 118 
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had been achieved and data collection could cease. Data saturation was achieved at each time point 119 
despite fewer interviews being conducted over time (see findings). 120 
To capture a broad range of experiences relating to caring for a family member through 121 
chemotherapy, carers were selected purposively according to: treatment intent (curative/palliative); 122 
age (younger /older than retirement age); gender and, relationship to the patient (spouse/partner 123 
and other relationships). 124 
 125 
2.3. Qualitative interviews 126 
The study was approved by the North London REC3 (now London-Harrow NHS Ethics 127 
Committee) REC Ref: 11/H0709/2.  The first interview (T1) asked about: perceptions and 128 
expectations of chemotherapy; changes to everyday life that had been introduced; information and 129 
support needed; and that provided by healthcare professionals.  The second (T2) focused on: status 130 
of work and other commitments since previous interview; symptoms, side-effects and unplanned for 131 
events (e.g. hospitalisation) experienced by their relative; help-seeking undertaken; experience of 132 
caring; feelings of confidence and competence in caring; needs for information and support and 133 
level to which they were met.  The final interview (T3) was similar to T2 except it additionally 134 
discussed carers’ experiences of chemotherapy in relation to their expectations at the start.   135 
Interviews were undertaken by two researchers (JF-J and RF), varied in length from 11 136 
minutes to 1.5 hours, were recorded digitally and were professionally transcribed. They were 137 
undertaken in a venue of carers’ choice: 18 were undertaken in carers’ private homes; 19, over the 138 
telephone; 23, within the hospital setting, and 3, at the carers' workplace. 139 
 140 
2.4. Data analysis 141 
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Interview data were analysed using Framework Analysis (Ritchie & Lewis, 2003), a matrix-142 
based approach for collating, reviewing and understanding qualitative data- suitable for analysing 143 
longitudinal data (Ritchie & Lewis, 2003). A thematic coding framework was devised from recurrent 144 
themes within the data (RF, JFJ, ER) and applied across transcribed accounts (RF, JFJ). Coded data 145 
were transferred to a matrix that allowed data from each of the interviewees’ three interviews to be 146 
integrated (rather than analysing each set of interviews independently).  Matrices incorporated both 147 
narrative summary and relevant quotes in accordance with the Framework Analysis approach (see 148 
Figure 1a).  149 
[insert Figure 1 here] 150 
 151 
The data were analysed both cross-sectionally through construction of matrices (Figure 1a), 152 
and longitudinally (Calman et al., 2013) through mapping individuals’ data  over the three time 153 
periods (Figure 1b). These processes enabled identification of both convergent and divergent 154 
experiences between carers at each time point and the capture of within- individual dynamics.  It 155 
was possible to identify changes in experiences and perceptions over time, both within and across 156 
individuals, to explore how these arose and to posit some explanations for them. Data analysis 157 
commenced as data were generated and was iterative; the researchers moved back and forth in a 158 
systematic manner between generating interview data and analysing them thus allowing areas of 159 
questioning to develop as understanding of an area grew or additional clarity was sought.  160 
 161 
3. Findings 162 
One hundred and one patients were screened for eligibility and 64 eligible carers were 163 
approached about the study in order to consent 25 carers as planned. Five carers withdrew before 164 
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the second interview, and a further two before the third.  Withdrawals followed deterioration in 165 
patients’ health or their death (see Figure 2).  166 
[insert Figure 2 here] 167 
Seventeen female and 8 male carers were recruited, their average age was 53 years; most 168 
were a spouse/partner (n=19). Fifteen carers were supporting a patient having curative 169 
chemotherapy (marked ‘C’ before the participant’s number). The remainder supported patients 170 
having palliative chemotherapy (marked ‘P’) (see Tables 1 and 2 for participants’ details). 171 
[insert Tables 1 and 2 here] 172 
 173 
Data analysis identified three themes that which reflected carers’ experiences and support 174 
needs over time: Changing lives, Changing roles; Confidence in caring, and Managing uncertainty. 175 
These themes endured over time but some aspects of them – sub-themes – varied as treatment 176 
progressed and patients’ needs altered. Some appeared linear with trends (either improvement or 177 
decline) over time, whilst others had no evident pattern. Some differences in carer experience were 178 
evident according to the intent of patients’ treatment (curative versus palliative) (see Table 3).  179 
[insert Table 3 here] 180 
3.1. Changing lives, changing roles  181 
The first theme indicates how, across time, carers’ lives changed as did the roles they 182 
undertook in supporting patients. Carers found that they rapidly (from T1) had to undertake more 183 
roles within the home as many relatives’ felt the immediate effects of treatment.  These obligations 184 
grew with time (T2 and 3) and many carers felt accompanying stress.  The changing domestic 185 
dynamic appeared to have a knock-on effect that was felt more keenly over time (by T2 and T3) on 186 
relationships with some becoming stronger and others frayed.  Concerns over financial stability were 187 
constant (present from T1 and persisting to T3) and influenced by working carers’ decisions to 188 
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decrease (due to caregiving requirements) or increase (due to financial need) employment as 189 
needed.  A balance was evident for those of working age – between caregiving and working - that 190 
was challenging for some to achieve.   191 
3.1.1.  You doing everything 192 
At the start of treatment, carers described how their lives had been disrupted by the 193 
patient’s cancer diagnosis and the many new roles that they undertook in caring for their relative. 194 
They were willing to provide care and wanted to help, but the impact was immediate: 195 
Well, every day after work I have to come over here or I meet my mum and we go to 196 
treatment. Or whatever days I’m off I’m over here, cleaning the house, cooking and washing 197 
clothes and make everything sterile and make sure everything’s clean so that she doesn’t get 198 
an infection…  I live on my own so it’s like living two lives. (C4, F, 28, daughter) 199 
By the second interview, a pronounced sense of chemotherapy taking over carers’ lives was 200 
evident as caregiving roles began outstripping other social roles and caregiving became ‘a job in 201 
itself’. Carers not used to housework, or caring in a physical capacity, felt an acute sense of strain. 202 
Some carers of people having curative treatment struggled with the ongoing burden of caregiving 203 
and voiced some growing frustration and resentment:    204 
Yeah still doing it all but resentments kicked in. I don’t know if I said that last time, I think it’s 205 
just a recent thing. Because when he was in hospital I kept going because you do. But when 206 
he’s home and he’s just laid there, you doing everything, you’re tidying up, you’re doing the 207 
kitchen, you cutting the grass and he’s just sat there and you think you know he can’t, but at 208 
the same time you [think], lazy git. (C5, F, 44, partner) 209 
It was clear that the stress felt by carers, created by caregiving during chemotherapy, did not abate 210 
with time.  A high level of unremitting stress, that commenced when chemotherapy started, was felt 211 
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by all carers.  The burden of helping to manage patients’ treatment and the associated disruption to 212 
carers’ lives appeared to increase with time.   213 
 214 
3.1.2. Impact on our interactions 215 
Carers accounts made it evident that relationships between carers and patients often 216 
changed over the course of chemotherapy; for some relationships improved, whilst for others they 217 
declined.  By treatment mid-point, carers’ everyday roles had changed – many had to undertake 218 
additional household chores and were instrumental in ensuring patients attended appointments, 219 
took medications and attained help from clinical teams if they become unwell.  While for some 220 
patient-carer dyads, this changed dynamic within relationships and the home helped to make bonds 221 
between them stronger, others found relationships became strained: 222 
It would be easy for me to feel that she doesn’t always appreciate what I do for her but there 223 
again you can’t expect people to be continually grateful for what you’re doing… Just 224 
occasionally, erm, she’ll be feeling so fed up that, erm… that does impact on our interactions. 225 
(P10, 78, M, husband) 226 
The impact of treatment on personal connections extended to broader relationships. Some 227 
carers felt distanced from family members and friends and unable to engage in everyday social roles 228 
through needing to be at home. They described feeling ‘isolated’ and struggling to commit to 229 
arrangements (P5, 35, M, fiancé). In contrast, other carers, particularly those caring for a relative 230 
having palliative chemotherapy, reported feeling closer to, and very supported by, other members of 231 
their family. One man caring for his wife with mesothelioma described how his bond with his sons 232 
had strengthened: 233 
My two boys now, we now go out every two or three weeks on a Saturday. We have lunch 234 
and then we have a few beers, which we never used to and I think this is all because they are 235 
                                                      LONGITUDINAL QUALITATIVE STUDY WITH INFORMAL CANCER CARERS 
12 
 
looking out for me. […] We never used to do it on a regular basis it’s about time we did, life’s 236 
too short, as I said, and now we do that. (P7, M, 68, husband) 237 
Thus, although there was a trend over time for carers’ relationships to be altered, these could 238 
become either fractured or enhanced during chemotherapy according to individual circumstance.  239 
Further, this could apply to relationships with not only with the patient but also with their wider 240 
family, friendships and social groups. 241 
 242 
3.1.3. I’m the breadwinner 243 
Thirteen carers were in employment at some point during data collection. At first interview, 244 
they reported challenges with balancing demands of caring with those of work:  245 
I’m the breadwinner at the moment and I need to keep that going so it is difficult. Mentally, I 246 
can cope when I haven’t got to do the work-side and just concentrate on him and the house. 247 
(C5, F, 44, partner) 248 
Concerns over financial stability were clear from the outset for most carers.   Their anxieties 249 
were compounded or lessened according to employers’ attitudes and practices.  Some carers 250 
reported having flexible and understanding employers who allowed them time off to support 251 
patients at appointments or though periods of acute illness.  However, others had inflexible 252 
employers; it was not uncommon for them to take unpaid leave or holiday to cover caregiving 253 
responsibilities, making their support of patients harder to manage.  254 
Carers’ concerns over remaining in employment, and earning sufficiently to support their 255 
needs, were unabating over the course of their relatives’ treatment.  Indeed, by the third interview, 256 
the need to work reduced the level of support some carers could offer patients, e.g. some needed 257 
other family members or friends to attend patients’ treatment in their place. Carers’ work 258 
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commitments were often driven by reduced financial circumstances due to patients’ inability to 259 
work.   260 
 261 
3.2. Confidence in caring  262 
The second theme reflects carers’ confidence in supporting their relative through 263 
chemotherapy and managing the side-effects associated with it. Three sub-themes were evident 264 
that showed how carers collectively progressed from: trepidation over side-effects and uncertainty 265 
about when and how to seek help for them (T1); to growing confidence in recognising and 266 
addressing important side-effects (T2); to, the caregiving process becoming routine or second-nature 267 
(T3).  268 
3.2.1. We weren’t sure if it was a problem 269 
During the first interview, carers expressed trepidation over monitoring chemotherapy side-270 
effects. Some felt well-prepared – buoyed by the assumption that they would have easy access to 271 
healthcare professionals to convey ‘look, this is happening, or, I can’t do this, or so on and so forth. 272 
Help!’ (P7, 68, M, husband). In practice, this contact and reassurance was not always forthcoming. 273 
One carer explained how she could not access help over the weekend, while others found it 274 
challenging to decide what constituted an ‘urgent’ concern:  275 
…you can page a registrar if it’s urgent but we weren’t sure if it was a problem or if it was 276 
urgent, so that was probably the most stressful thing, not knowing whether you should 277 
phone them in the middle of… it was only like 11pm but whether just to… so we just waited 278 
until the morning. (C11, 27, F, girlfriend) 279 
 280 
3.2.2. You know what to look out for 281 
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By treatment mid-point, carers felt more confident in recognizing severe symptoms and had 282 
a better understanding of when help-seeking for them was warranted: 283 
I think as it’s gone on, you just know what to look out for and you kind of get a feel for what’s 284 
a problem and what isn’t too much of an issue, and just getting used to it, I think. (C11, 27, F, 285 
girlfriend) 286 
However, as at T1, they believed it essential to have direct access to healthcare 287 
professionals when required in order to continue building and maintaining confidence in caregiving. 288 
Carers felt more confident in caregiving when they received prompt help from healthcare 289 
professionals, and when they trusted their acute oncology service. Where help-seeking had proved 290 
difficult early in the treatment trajectory, carers remained concerned over monitoring and managing 291 
acute treatment toxicities.  292 
3.2.3. Doing it all the time 293 
By the end of treatment, most carers reported feeling confident in their ability to support 294 
their relative through chemotherapy and its associated side-effects.  This reflected their familiarity 295 
through ‘doing it [caregiving] all the time’. However, when new - or less tangible - symptoms arose 296 
e.g. fatigue or weakness, carers reported feeling unsure of how best to help. This undermined some 297 
carers’ confidence in their ability to resolve issues and concerns. They also perceived that their 298 
confidence in caregiving was enhanced through establishing trusting relationships with healthcare 299 
professionals: 300 
I got more confident because I knew what I was doing, I knew where I was going. The people 301 
were recognisable, they all recognised [patient] and, you know, if I had any problems I felt 302 
that they were friendly enough and easy approachable, not sort of someone that I would find 303 
intimidating or anything. I could just go up to them and sort of say… no matter if it was a 304 
little thing that, you know, oh we’ve been feeling like this, is this normal? (C8, 51, F, mother) 305 
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Whilst time and experience increased carers’ confidence in managing side-effects and in 306 
gaining help when it was needed, some carers retained elements of uncertainty and felt strong need 307 
for ongoing guidance from healthcare professionals. 308 
 309 
3.3. Managing uncertainty  310 
This theme reflects the manner in which carers experienced uncertainty across the course of 311 
patients’ chemotherapy with them expressing trepidation at first (T1) and associated anxiety.  312 
Thereafter, they referred to the benefits of routine as they adjusted to the ‘new normal’ of living 313 
through chemotherapy and of feeling more in control (T2).  Towards the end of treatment (T3) 314 
carers were reflective and voiced new concerns, renewed anxiety and increased trepidation as 315 
treatment ended.  There appeared some differences according to whether patients’ treatment was 316 
either curative or palliative.    317 
3.3.1. Steel myself for anything  318 
As treatment started, carers voiced concerns about the future, notably about treatment 319 
side-effects that they were anticipating. For carers of people having curative chemotherapy, 320 
uncertainties became more pronounced as the reality of treatment set in and anxieties manifested 321 
about how their relatives would manage: 322 
Well I thought to myself well I’d better steel myself for anything here because I don’t know 323 
how it’s going to affect her every day, and I was getting a bit concerned about whether she 324 
would be able to, would she be in a state to be at home on her own if I was working. (C3, M, 325 
63, husband). 326 
For some, concerns over disease recurrence appeared at the root of their anxieties; they 327 
were concerned that their relative would undergo unpleasant side-effects and risks of chemotherapy 328 
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without attaining the intended remission from disease. Three carers of people having curative 329 
chemotherapy reported physical complaints at T1 which they related to stress.  330 
Carers of people having palliative chemotherapy expressed less anxiety at the start of 331 
treatment, as they ‘just had to deal with it’ (P8, F, 33, daughter). They articulated acceptance and 332 
viewed treatment as offering hope whilst acknowledging that death might be inevitable. Carers’ 333 
desire for information about prognosis varied: information helped some manage uncertainty – they 334 
wanted to know ‘what to expect’ (P7, M, 68, husband), whilst others felt strongly that they did not 335 
want to know more. One explained ‘when we saw the oncology specialist at X hospital well she went 336 
into so much detail, and we thought why do we need all this detail, you know’ (C12, M, 78, husband).   337 
 338 
3.3.2. Taking control 339 
By treatment mid-point, carers voiced how routines of treatment – and the familiarity of 340 
associated symptom patterns – reduced uncertainty. Although caregiving and the demands of 341 
patients’ treatment remained unremitting, knowledge of what was happening provided a sense of 342 
control:  343 
I know what the routine is and I expect him to be slightly more poorly in his full week than 344 
the week that he is doing one day. So I think, you come to terms with it... I mean, it’s become 345 
like a routine now. I know what’s expected. I know it’s going to take 5 hours and I try to 346 
manage my time… it’s become a bit more… not easier, but it’s become a bit more routine 347 
because I know what to do now. (C8, 51, F, mother) 348 
However, this was not the same for everyone – for some, the side-effect patterns (with 349 
marked peaks and troughs) stimulated pre-emptive worry over future cycles of treatments and 350 
potential difficulties.  351 
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Many carers of people having palliative treatment reported that side-effects were fewer 352 
than anticipated and they talked positively (as they had at T1) about the ‘glimmer of hope’ (P8, 33, F, 353 
daughter), sense of ‘momentum’ and ‘taking control’ that treatment provided (P3, 54, F, daughter). 354 
However, for some, fears about how they would manage if the patients’ health declined had turned 355 
to ‘dark moments’ and ‘anger’ (P7, M, 68, husband). 356 
In contrast, carers of people having curative treatment voiced a sense of the journey 357 
peaking, with side-effects taking longer to subside and their own energy running low. These carers 358 
reflected on a new normality shaped by cancer and its treatment, and their reflections were tinged 359 
with anxiety when they (often erroneously) interpreted side-effects as signs of cancer spreading.  360 
 361 
3.3.3. How do we get to the other side? 362 
The final interview provided a chance for carers to reflect. For carers of people having 363 
palliative chemotherapy, there was a sense that chemotherapy had been ‘a lot less scary’ than 364 
initially feared (P8, F, 33, daughter). However, the end of treatment also heralded feelings of anxiety 365 
for them; concerns remained over how patients could deteriorate and how they would cope as end 366 
of life neared. For carers of people having curative chemotherapy, anxiety and stress appeared 367 
cumulative. Carers spoke of the need to transition to ‘the other side’ of treatment as they 368 
contemplated what might happen next: 369 
… now everything’s over it’s actually, oh my god, we’ve just done all that and we’ve survived 370 
[to] the other side, because before we started I said to [patient] how do we get to the other 371 
side when we get there?’ (C5, 44, F, partner) 372 
As one carer articulated, her worries were ‘always going to be there’ in the future as 373 
monitoring and check-ups continued (C8, F, 51, mother). After the routine of treatment and 374 
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structure of appointments, there emerged a return to uncertainty – as one participant explained, 375 
there was an acute sense of uncertainty over ‘what does the future hold?’ (P8, 33, F, daughter). 376 
 377 
4. Discussion  378 
This is a first study of its kind to describe the experiences over time of carers supporting 379 
family members through chemotherapy, and to detail how their needs for support and their 380 
confidence in providing care change over the course of treatment. Further, it allowed comparison 381 
between the experiences of carers according to whether their relatives were being administered 382 
curative or palliative treatment.  The study’s longitudinal qualitative design captured the changes 383 
over time in carers’ experiences and identified how they could vary according to patients’ disease 384 
status, treatment intent and individual circumstance.    385 
Across the sample, there was a sense that carers – whilst willing to support their relatives 386 
through chemotherapy – sometimes felt overwhelmed by the burden of patients’ illness and its 387 
associated treatment. Past research has established that treatment itself is burdensome and can 388 
disrupt patients’ daily lives, decrease their desire to follow onerous and complex treatment 389 
schedules and diminish patients’ overall quality of life (May et al., 2009). We argue that these 390 
burdens are experienced as much by carers as patients. Indeed, previous literature suggests that 391 
cancer carers can be profoundly affected during patients’ chemotherapy (Grunfeld et al., 2006; 392 
Jenewein et al., 2008). Carers report that the changes to everyday lives, required to support 393 
someone through chemotherapy, are challenging to adapt to (McIlfatrick et al., 2006; McKenzie et 394 
al., 2017; Schmer et al., 2008). This study identified that carers in employment – particularly those 395 
struggling to meet work commitments – are particularly vulnerable to burden and distress. Given 396 
that around 50% of carers are in employment (Kent et al., 2019), there is a sizeable population 397 
whose vulnerability and needs during patients’ chemotherapy need to be assessed and addressed. 398 
Further, this study ascertained that many work-related stressors arise at the start of treatment 399 
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suggesting that healthcare professionals need to be proactive at this time, as well as revisiting issues 400 
related to work later on.  401 
The importance to carers of having easy and quick access to health professionals to consult if 402 
their relative becomes unwell was evident in this study.  However, rapid and straightforward access 403 
was not experienced by all carers.  This was particularly problematic if lack of support was 404 
encountered early in treatment - when carers had uncertainties over what to expect or how to go 405 
about help-seeking.   Challenges with consulting with professionals will arguably contribute to the 406 
isolation, fear and low confidence in caregiving that some carers report (Ream et al., 2013). Further 407 
these feelings are liable to increase any anxiety and depression; levels of anxiety in carers can be 408 
higher than those experienced by patients and endure for at least five years following patients’ 409 
diagnosis (Girgis et al., 2013).   410 
This study, one of only a few to investigate carers’ experience and needs over time, found 411 
that their contributions to carers’ roles and contributions (McIlfatrick et al., 2006) in a somewhat 412 
static fashion, failing to highlight the dynamic nature of their caregiving contribution. Further, this 413 
study depicted how carers’ confidence in caregiving grew as treatment progressed as long as they 414 
could access appropriate help when needed. With the advent of acute oncology services, the 415 
challenge for patients and carers of gaining quick access to oncology professionals when needed has 416 
largely lessened (Neville-Webbe et al., 2013). 417 
It was also noteworthy how the outlook and perceptions of chemotherapy held by our study 418 
participants – as either a treatment to be feared or one offering hope – differed according to 419 
whether chemotherapy was being given to prevent recurrence or as a palliative measure.  420 
Additionally, carers’ views on transition to life post-chemotherapy varied markedly although all were 421 
characterised by uncertainty, at marked odds to feelings of control generated by the routine of 422 
treatment. For carers of people having curative treatment, fear of recurrence was evident. For those 423 
caring for people completing palliative treatment, uncertainties predominantly centred around the 424 
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length of time before disease would progress and their – and patients’ – likely resilience as end of 425 
life neared. The literature increasingly refers to patients’ fear of recurrence and this concept is 426 
relatively well-researched (Armes et al., 2009); however, the nature of fear of recurrence and/or 427 
progression held by carers is much less researched, with few exceptions (Hodges & Humphris, 2009). 428 
Our research suggests that it is important for healthcare professionals to: i) appreciate 429 
differing perspectives held by carers towards chemotherapy according to patients’ prognosis and 430 
treatment intent; ii) understand how carers’ ability to provide care and associated burdens of caring 431 
are affected by both patient need and their own capacity to care; iii) recognise the challenge for 432 
carers on transition to life following chemotherapy, and iv) develop and institute appropriate 433 
supportive interventions for carers that can accommodate their changing experience and need.   434 
It is important to note that our research focused solely on people that had carers; not every 435 
person with cancer has a family member or friend to look after, and support, them through 436 
chemotherapy.  It is important that the experiences of people without carers to call upon are 437 
understood as these patients are likely to find the rigours and burdens of treatment harder to 438 
contend with than their counterparts with carers.  Interestingly, this group has been the subject of 439 
little research to date.  440 
 441 
4.1 Strengths and limitations of the study 442 
One strength of this study lies in its longitudinal qualitative design which enabled carers’ 443 
experiences to be captured along the treatment trajectory, advancing much needed 444 
conceptualisation of their experiences (Fletcher et al., 2012) and their adjustment to their role. 445 
Whilst a few other studies (e.g. Taylor et al., 2016) have taken a longitudinal qualitative approach to 446 
explore carers’ experiences during patients’ treatment for cancer, they have not specifically focused 447 
on how carers’ experiences vary during chemotherapy – a particularly challenging form of treatment 448 
that can pose high risk to patients.  449 
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The main limitation to the study lies in the fact that the findings represent only some carers’ 450 
experiences. From 64 eligible carers approached about the study, around 60% (of either patients or 451 
their carers) declined participation as they felt that they had too much to deal with without taking 452 
part. Arguably, the carers and patients who declined participation may have had more acute needs 453 
and/or more diverse experiences than the ones who participated.  454 
Additionally, it was not possible to comment on the experience over time of those who 455 
withdrew between the first and last interview. These carers withdrew because either their relatives’ 456 
health had declined or they had died.  457 
The majority of those interviewed were the patients’ partner or spouse. However, these 458 
carers intimated during their interviews, that wider family members were affected by their relatives’ 459 
chemotherapy and were also involved in – and affected by - caregiving. These carers were not 460 
represented within our sample.  The complexity of situations involving multiple carers warrants 461 
further investigation. 462 
Another potential limitation to the study relates to the fact that we recruited only carers of 463 
people being treated with cisplatin-based treatments; treatments known to have significant toxicity. 464 
It is possible that carers looking after patients receiving different chemotherapy treatments may 465 
have had different experiences from those captured in this study.  466 
 467 
5. Conclusions  468 
Chemotherapy is – and will remain – an important treatment for cancer for the foreseeable 469 
future and will continue to be delivered primarily in day care settings.  This requires carers to take 470 
considerable responsibility for patient wellbeing at home. Carers play an important role in patient 471 
safety – recognising and responding to symptoms and knowing when to access help for acute 472 
toxicities which can lead to sudden patient deterioration. It is essential that healthcare professionals 473 
prepare carers and ensure that they are well equipped for, and supported in, caregiving in; this will 474 
help to safeguard patient safety. Carers’ input enables healthcare services to operate and 475 
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contributes substantially to cost reduction at the end of life (Round et al., 2015) as patients and 476 
clinicians rely on carers’ support and care management skills (McKenzie et al., 2017). This study 477 
suggests that some carers are at risk of becoming overburdened by requirements imposed by 478 
patients’ illness, fear for the future and requirements of treatment. However, conversely carers can 479 
be very positive, upbeat and manage caring without detriment to their own wellbeing. Thus, it is 480 
important that they have their caring ability and needs assessed, particularly as they may be 481 
reluctant to ask for support (Renovanz et al., 2018).  The demands on them – and their needs for 482 
assistance – are often overlooked (Ussher et al., 2009). Given the dynamic nature of carers’ 483 
experiences, this study suggests that their needs should be assessed periodically.   484 
 485 
Finally, as indicated in previous research focusing on cancer carers’ needs (Ream et al., 486 
2013), this study points to the need for carer interventions that prepare carers for, and sustain them 487 
during, caregiving. Such interventions need to be pragmatic and feasible to deliver in what is 488 
effectively a clinical busy setting. One intervention – Take Care® – reported in the literature outlines 489 
the potential of a brief educative intervention for enhancing carers’ self-efficacy for caregiving 490 
during chemotherapy (Tsianakas et al., 2015). It is the only intervention written about in the 491 
literature developed specifically for supporting cancer carers during this time. This is clearly an area 492 
that needs greater research and development in future.   493 
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Figure 1. Extracts depicting data analysis process 641 
1a: Example of matrix used in longitudinal analysis: Combining working and caring responsibilities 642 





Combining working and caring responsibilities 
C3 F 
Curative 
Husband T1: Finding it very tiring combining work and caring responsibilities 
T2: Difficulties juggling both. ‘… there were times when she [his 
wife] was so bad that I had to ring up work and say I can’t come in 
I’ve got to help, you know…’.  Work have been very accommodating. 
T3: No data – no interview possible  
C6 M 
Curative 
Wife T1: Has had to use annual leave to accompany husband to hospital.  
Only two days paid leave left. 
T2: Still working, employers really supportive allowing her to take 
time off as required. Annual leave nearly run out.   
T3: Continuing working.  Taking unpaid leave as needed. 
C11 M 
Curative 
Girlfriend T1: Not working.  Appears overwhelmed emotionally, exhausted. 
Recognises if did work she’s unsure how she would accommodate 
chores, caring responsibilities as well as job 
T2: Mentions she is a procrastinator.  Wants to look for work, but 
finding it hard to get motivated to do this. 
T3: Back in work but: ‘it’s been really hard doing both at once and I 
do kind of feel it must be what Mums feel like when they go back to 
work, like I’m not doing really either of them properly - but erm, I 
think I’m seeing it as a short-term thing and the hoping if you know 
all is well with his scan results…I’d rather work at the moment while 
he is able to get up and about and do things for himself’. 
P1 M 
Palliative 
Wife  T1: Working: using free periods (is supply teacher), when she 
doesn’t need to be at school, to be with her husband.  Has two 
lodgers who she now has to cook for (husband was responsible for 
household tasks).  They have livestock that need taking care of.   
T2: Livestock have been moved closer to home so that she can keep 
an eye on them more easily. 
T3: Trying to ensure hospital appointments are scheduled so that 
she doesn’t have to take time off work.  But if she needs to, she will.   
P8 M Palliative Daughter T1:  Not working 
T2: Stresses her father is her priority, but struggling without regular 
income, looking for flexible freelance jobs.  Finds it difficult not 
being able to afford simple things to cheer herself up. Everything a 
‘juggling act’ especially as she also has chronic illness herself. 
T3: Now working so unable to accompany her father to treatment, 
boyfriend is helping out… ‘the big factor now is there’s not anyone 
that’s really replaced my time with Dad, so you know, it’s quite 
snatched time I’m spending with him now. With his last chemo my 
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Relief treatment has 
started. Anticipates 
side-effects.
•Managing uncertainty:  
Relief - that treatment 
is possible and has 
started.  Reflecting on 
pt mortality.  Doesn't 
want to know how 






Fears over side effects 
unfounded. Patient 
managing chemo well.  
Seeking practical help 
(mobility car).
•Managing uncertainty: 
Reassessing - Not 
seeing diagnosis 'as 
death sentence'.  
Hoping there is 






worried re future 
decline
•Confidence in caring:
Keeping positive, will 
cope going forwards
•Mangaing uncertainty: 
Faith: has faith in the 
treatment. Doesn't want 
to know if it has been a 
success.  Doesn't want 
to know how much time 
he has left
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  673 
101 patients screened 
30 patients not approached 5 ineligible 66 patients approached 
2 ineligible (no carer) 
64 patients with eligible carer 
28 patients consented 
39 patients and/or carers 
declined 
25 carers consented 
25 carers completed Interview 1 
 
20 carers completed Interview 2  
18 carers completed Interview 3  
5 carers: Withdrawn 
2 carers: Interviews 2 & 
3 amalgamated 





Table 1. Characteristics of carers recruited to the study 676 
Age                                                        Mean 52.6 (range 18-78) 
 N                                            % 
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P1 51 Female Wife Lung Palliative >2-4 months 
P2 35 Female Wife Lung Palliative >2-4 months 
P3 54 Female Daughter Lung Palliative >2-4 months 
P4 65 Female Wife Lung Palliative >2-4 months 
P5 35 Male Fiancé Colorectal Palliative >2-4 months 
P6 60 Female Wife Colorectal Palliative >4 months 
P7 68 Male Husband Mesothelioma Palliative >4 months 
P8 33 Female Daughter Mesothelioma Palliative >4 months 
P9 67 Female Wife Lung Palliative <2 months 
P10 78 Male Husband Ovarian Palliative >2-4 months 
C1 75 Male Husband Lung Curative <2 months 
C2 60 Female Wife Lung Curative >4 months 
C3 63 Male Husband Colorectal Curative >2-4 months 
C4 28 Female Daughter Cervical Curative <2 months 
C5 44 Female Partner Lung Curative <2 months 
C6 29 Female Wife Testicular Curative >2-4 months 
C7 65 Female Wife Colorectal Curative >4 months 
C8 51 Female Mother Testicular Curative >2-4 months 
C9 25 Female Daughter Lung Curative <2 months 
C10 71 Male Husband Cervical Curative >4 months 
C11 27 Female Girlfriend Colorectal Curative >4 months 
C12 78 Male Husband Ovarian Curative >4 months 
C13 66 Female Wife Colorectal Curative >4 months 
C14 70 Male Husband Endometrial Curative >4 months 
C15 18 Female Daughter Cervical Curative <2 months 
 680 
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Table 3. Change in carers’ needs and experiences over time 682 
 683 
 Constant Fluctuating;  
no evident pattern 
Increasing 
with time 
Theme 1: Changing lives, Changing roles 
Changed role at home, burden of 
responsibility (Subtheme: You do everything) 
  * 
Stress & worry over maintaining work 
and/or duties in the home & caring 
responsibility (Subtheme: You do everything) 
*   
Impact on relationships; either 
strengthened or strained (Subtheme: Impact 
on interactions) 
  * 
Financial worries (Subtheme: I’m the 
breadwinner) 
*   
Theme 2: Confidence in Caring 
Need for health care professional input, 
support & information (Subtheme: We 
weren’t sure it was a problem) 
*   
Confidence in accessing help & identifying 
problems (Subtheme: You know what to 
look out for; Doing it all the time) 
  * 
Challenges with new symptoms and 
situations (Subtheme: We weren’t sure it 
was a problem) 
 *  
Theme 3: Managing Uncertainty 
Fear about recurrence or spread (Curative 
patients) (Subtheme: Steel myself for 
anything) 
*   
Worries about patient’s decline and end of 
life (Palliative patients) (Subtheme: How do 
we get to the other side?) 
  * 
Belief that treatment offers hope (Palliative 
patients) (Subtheme: Steel myself for 
anything) 
*   
Needs for information (Subthemes: Steel 
myself for anything; Taking control) 
*   
Anxiety and stress (Subthemes: Steel myself 
for anything; How do we get to the other 
side?) 
 *  
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